Vivaldi Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
2,239
-72
| -3% | -$9.11K | 0.04% | 229 |
|
|
2025
Q1 | $296K | Sell |
2,311
-752
| -25% | -$96.2K | 0.05% | 207 |
|
|
2024
Q4 | $424K | Sell |
3,063
-1,725
| -36% | -$239K | 0.07% | 163 |
|
|
2024
Q3 | $697K | Buy |
4,788
+6
| +0.1% | +$874 | 0.2% | 90 |
|
|
2024
Q2 | $656K | Buy |
4,782
+100
| +2% | +$13.7K | 0.19% | 105 |
|
|
2024
Q1 | $625K | Sell |
4,682
-78
| -2% | -$10.4K | 0.18% | 108 |
|
|
2023
Q4 | $630K | Sell |
4,760
-112
| -2% | -$14.8K | 0.19% | 110 |
|
|
2023
Q3 | $596K | Hold |
4,872
| – | – | 0.19% | 99 |
|
|
2023
Q2 | $619K | Hold |
4,872
| – | – | 0.19% | 97 |
|
|
2023
Q1 | $629K | Sell |
4,872
-304
| -6% | -$39.3K | 0.19% | 99 |
|
|
2022
Q4 | $674K | Buy |
5,176
+1
| +0% | +$130 | 0.17% | 119 |
|
|
2022
Q3 | $615K | Buy |
5,175
+498
| +11% | +$59.2K | 0.17% | 103 |
|
|
2022
Q2 | $550K | Hold |
4,677
| – | – | 0.14% | 118 |
|
|
2022
Q1 | $529K | Sell |
4,677
-663
| -12% | -$75K | 0.14% | 127 |
|
|
2021
Q4 | $815K | Hold |
5,340
| – | – | 0.19% | 95 |
|
|
2021
Q3 | $863K | Buy |
5,340
+2
| +0% | +$323 | 0.19% | 89 |
|
|
2021
Q2 | $904K | Buy |
5,338
+565
| +12% | +$95.7K | 0.18% | 95 |
|
|
2021
Q1 | $714K | Buy |
4,773
+2,647
| +125% | +$396K | 0.14% | 116 |
|
|
2020
Q4 | $322K | Buy |
2,126
+621
| +41% | +$94.1K | 0.07% | 178 |
|
|
2020
Q3 | $212K | Hold |
1,505
| – | – | 0.05% | 230 |
|
|
2020
Q2 | $201K | Buy |
+1,505
| New | +$201K | 0.04% | 246 |
|
|
2019
Q3 | – | Sell |
-7,222
| Closed | -$788K | – | 237 |
|
|
2019
Q2 | $788K | Sell |
7,222
-4,870
| -40% | -$531K | 0.21% | 107 |
|
|
2019
Q1 | $1.35M | Buy |
12,092
+9,339
| +339% | +$1.04M | 0.38% | 70 |
|
|
2018
Q4 | $265K | Buy |
+2,753
| New | +$265K | 0.11% | 150 |
|